Colon & Rectal Surgery Consultants
2306 Knob Creek Road
Johnson City, TN 37604
Dr. Connie Pennington, MD
Genetic Testing for Colon Cancer
Hereditary Cancer Panel
Myriad myRisk™ Hereditary Cancer is a scientific advancement revolutionizing hereditary cancer testing. Blending both genetic test status AND personal cancer family history, Myriad myRisk hereditary cancer panel represents the next generation of hereditary cancer risk testing. Myriad myRisk identifies elevated risk for 8 important cancers by analyzing multiple, clinically significant genes. Additionally, Myriad myRisk provides a summary of available medical society guidelines to help you optimize your patients’ medical management. Be confident you know your patients’ cancer risks and appropriate follow-up management with Myriad myRisk Hereditary Cancer.
We suggest genetic testing for patients with the following known risk factors:
Personal or Family history of Colorectal cancer < age 50
Personal or Family history of Breast or Endometrial cancer < age 50
Personal or Family history of Ovarian Cancer
Male breast cancer at any age
Personal or Family history of more than one primary cancer
Family with two or more associated cancers (breast, colorectal, ovarian, endometrial, gastric, pancreatic, melanoma, or prostate cancer
>10 or more colon adenomas
Dr. Pennington and Dr. Sheffey offer myRisk testing in the office to eligible patients. Myraid verifies insurance coverage and any out of pocket expenses in excess of $375 prior to testing.
This test is a saliva test and requires 30cc of saliva. You must not eat, drink, or smoke 30 minutes prior to testing.
We are now utilizing Pathway Genomics to better serve our surgery patients. Genetic testing is performed via a blood sample to determine individual metabolic profiles and drug metabolism. The Pain Medication DNA Insight tells us which narcotic and non-narcotic medications will work best in the post-operative period. The Cardiac DNA Insight tests for the genetic risk of a variety of health related cardiovascular conditions, including blood clotting risk, that help us determine the best post-operative treatment plans. This service is covered by Medicare.